Health Care Mutual Funds: By investing in sectoral funds, an investor can diversify across different companies in a certain industry in addition to benefiting from the growth of that area. With a cumulative annual growth rate (CAGR) of more than 9.43% over the previous nine years, the pharmaceutical industry is among India’s top industrial sectors. You can profit from India’s expanding pharmaceutical sector by investing in these top pharma and health care mutual funds.
1. LIC MF Healthcare Fund Direct – Growth
LIC MF Healthcare Fund Direct – Growth has demonstrated strong performance, offering impressive 3-year annualized returns of around 18.78%. While it carries a high-risk profile, the accessible minimum SIP amount of just Rs. 200 makes it an appealing choice for both new and seasoned investors. With an AUM of Rs. 86.26 crores in 2025 and a robust 97% allocation to equity, this fund is well-positioned to deliver long-term growth. If you’re seeking to maximize your returns in the healthcare sector, this fund deserves serious consideration.
2. Mirae Asset Healthcare Fund Direct – Growth
Mirae Asset Healthcare Fund Direct – Growth is going to give around 19.36% returns in 3 years of annual investment. This is also said to be at high risk. The minimum amount to be invested in these mutual funds is just Rs 99, and as of 2025, the AUM of the company is around Rs 2,863.52 crores. According to the portfolio, around 99.2% of the funds are allocated to equity, and only 0.8% is allocated to cash. According to the experts, these funds are also good to invest in to get long-term returns.
3. ITI Pharma and Healthcare Fund Direct – Growth
ITI Pharma and Healthcare Fund Direct is considered to have high annual returns, which are around 20.99% for 3 years. This also carries a high risk; the minimum amount to be invested in these mutual funds is just Rs. 500. As of 2025, the company’s AUM is around Rs. 230.79 crores, and these mutual funds have allocated around 98.9% funds to equity, and just 1.1% is allocated in cash.
4. Tata India Pharma & Healthcare Fund Direct – Growth
Tata India Pharma & Healthcare Fund Direct is also considered to have the highest returns in the pharma mutual fund sector. These mutual funds are expected to give around 21.97% returns for 3 years. These mutual funds also carry high risk, but the minimum amount to be invested in this is Rs. 100. As of 2025, the company’s AUM is around Rs. 1,287.45 crores. According to the portfolio, around 94.9% of the funds are invested in equity, and around 5.1% is allocated to cash. It is said that these mutual funds are also the best option if you are planning to invest for the long term and high returns.
5. SBI Healthcare Opportunities Fund Direct Plan – Growth
SBI Healthcare Opportunities Fund Direct Plan is considered to be the highest return mutual funds in the Pharma sector. According to the portfolio, it is said that this has around 24.85% annual returns for 3 years. It is said that this is also having high-risk investment, and the minimum amount to be invested is just Rs. 500, and as of 2025, the company’s AUM is around Rs. 3,628.03 crores. As per the portfolio, the company has allocated around 96.5% of the funds in equity and 0.1% is allocated in debt, and just 3.4% is allocated in cash. According to the experts, it is said that this is one of the best pharma mutual funds to invest in 2025 for high returns.
Disclaimer: Mutual funds are subject to market risks. Please consult a financial expert before investing.

Share